Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2259
  • Dowloads 130

Case Reports

Open Access

Vulvar and gastric involvement in plasmablastic lymphoma

  • P. Almeida Galvão Ferreira1
  • C. Gomes Luna1
  • M. de França Silva2
  • L.C. Soares1,*,
  • M.A. Pinho de Oliveira1

1Gynecology Department, Rio de Janeiro State University, Rio de Janeiro, Brazil

2Pathology Department, Rio de Janeiro State University, Rio de Janeiro, Brazil

DOI: 10.12892/ejgo3506.2017 Vol.38,Issue 2,April 2017 pp.308-310

Published: 10 April 2017

*Corresponding Author(s): L.C. Soares E-mail: lcs1507@yahoo.com.br

PDF (576.18 kB) View Full-text

Abstract

Plasmablastic lymphoma is highly malignant and invasive. It is most commonly found in gastrointestinal tract and is strongly associated with human immunodeficiency virus (HIV). The authors report a case of a 37-year-old HIV-positive African American woman with a vulvar mass diagnosed as plasmablastic lymphoma. Involvement of the upper gastrointestinal tract had been detected by endoscopic biopsy, suggesting that any patient diagnosed with plasmablastic lymphoma in unusual locations should be investigated for primary lesions in the gastrointestinal tract.

Keywords

Plasmablastic lymphoma; Human immunodeficiency virus; Gastrointestinal tract.

Cite and Share

P. Almeida Galvão Ferreira, C. Gomes Luna, M. De França Silva, L.c. Soares, M.a. Pinho De Oliveira. Vulvar and gastric involvement in plasmablastic lymphoma. European Journal of Gynaecological Oncology. 2017; 38(2): 308-310. doi: 10.12892/ejgo3506.2017

URL:

https://www.ejgo.net/articles/10.12892/ejgo3506.2017

References

[1] Cheng M.H., Chao H.T., Wang P.H.: “Vulvar metastasis as the initial presentation of non-Hodgkin’s Lymphoma: a case report”. J. Reprod. Med., 2007, 52, 1065.

[2] Simard E.P., Engels E.A.: “Cancer as a cause of death among people with AIDS in the United States”. Clin. Infect. Dis., 2010, 51, 957.

[3] Reid-Nicholson M., Kavuri S., Ustun C., Crawford J., Nayak- Kapoor A., Ramalingam P.: “Plasmablastic Lymphoma: cytologic findings in 5 cases with unusual presentation”. Cancer, 2008, 114, 333.

[4] Liang R., Wang Z., Chen X., Bai Q.: “Treatment of plasmablastic lymphoma with multiple organ involvement”. Singapore Med. J., 2014, 55, 194.

[5] Castillo J.J., Reagan J.L.: “Plasmablastic lymphoma: a systematic review”. ScientificWorldJournal, 2011, 11, 687.

[6] Vega F., Chang C.C., Medeiros L.J., Udden M.M., Cho-Vega J.H., Lau C.C., Finch C.J., et al.: “Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles”. Mod. Pathol., 2005, 18, 806.

[7] Bibas M., Castillo J.J.: “Current knowledge on HIV-associated plasmablastic lymphoma”. Mediterr. J. Hematol. Infect. Dis., 2014, 6, 2035.

[8] Valera A., Balagué O., Colomo L., Martínez A., Delabie J., Tadesse- Heath L., Jaffe E.S., et al.: “Rearrangements are the main cytogenetic alteration in plasmablastic lymphomas”. Am. J. Pathol., 2010, 34, 1686.

Submission Turnaround Time

Top